rs587776867
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_015884.4(MBTPS2):c.1523A>C(p.Asn508Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N508I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_015884.4 missense
Scores
Clinical Significance
Conservation
Publications
- IFAP syndrome 1, with or without BRESHECK syndromeInheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet
- keratosis follicularis spinulosa decalvansInheritance: XL, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Olmsted syndrome, X-linkedInheritance: XL Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P
- osteogenesis imperfecta, type 19Inheritance: XL Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- mutilating palmoplantar keratoderma with periorificial keratotic plaquesInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- BRESEK syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- keratosis follicularis spinulosa decalvans, X-linkedInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 508 of the MBTPS2 protein (p.Asn508Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of ichthyosis follicularis, atrichia, and photophobia syndrome (PMID: 25683132; Invitae). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MBTPS2 protein function. This variant disrupts the p.Asn508 amino acid residue in MBTPS2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20672378). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at